Abstract:Guixian Li, 1 Wenbo Zhang, 2 Wei Gu 2 1 Department of Critical Care Medicine, Baoding First Central Hospital, Baoding, Hebei Province, People's Republic of China; 2 Department of Emergency Medicine, Chuiyangliu Hospital Affiliated to Tsinghua University, Beijing, People's Republic of China Correspondence: Wei Gu, Department of Emergency Medicine, Chuiyangliu Hospital Affiliated to Tsinghua University, No. 2 of Chuiyangliu South Street, Chaoyang District, Beijing, People's Republic of China, Tel +86 13633382381, Email Background: To assess the relationship between soluble interleukin-17 receptor (sIL-7R) levels and CD3-positive t cells and lymphocytes in patients with sepsis and their predictive clinical significance. Methods: The study cohort comprised individuals diagnosed with sepsis based on the Third International Consensus Definitions for Sepsis and Septic Shock, treated in the emergency and critical care medicine departments at Beijing Chuiyangliu Hospital and Baoding No. 1 Central Hospital between December 2020 and June 2022. Patient outcomes were classified based on survival or mortality. Biomarkers, including sIL-7R levels and illness severity scores, were documented. All statistical analyses, including predictive modeling and comparisons were carried out using SPSS v.23.0 software and R software. Results: On the fifth day post-admission, sIL-7R levels significantly decreased in both the survival and death groups, compared with levels on day one (2.09 ± 0.65 vs 1.07 ± 0.53 ng/mL, P < 0.01). There was a significant correlation between the sIL-7R level and the CD3+ T-lymphocyte count (CD3+) (r = 0.44) and lymphocyte count (LYM) (r = 0.42). The combination of the sIL-7R level with the Sequential Organ Failure Assessment (SOFA) score demonstrated optimal predictive value for clinical outcomes in patients with sepsis, demonstrated by an area under the receiver operating characteristic curve of 0.998. Conclusion: sIL-7R levels are correlated with CD3+ and LYM counts. Additionally, the combination of serum sIL-7R level and SOFA score provides a robust method for predicting sepsis outcomes. Keywords: immune function, prognosis, sepsis, soluble interleukin-7 receptor Sepsis is a critical medical condition characterized by systemic inflammation and multi-organ dysfunction, which often leads to life-threatening scenarios. 1 Recent research has shown that immune function plays a key role in the development and progression of sepsis. In particular, immunosuppression is a leading cause of sepsis-related death, 2,3 presumably due to the uncontrolled release of endogenous anti-inflammatory mediators. 4 In the early phases of sepsis, the release of pro-inflammatory cytokines induces the production of inflammatory mediators by target cells, culminating in a systemic inflammatory response syndrome 5,6 The increased production of cytokines in sepsis may result in lymphocyte apoptosis. 7,8 In some patients, the weakened immune response and reduced numbers of lymphocytes during a severe infection can result in immune paralysis. 9,10 There is growing evidence that immune-related factors can be used to assess the immune system of patients with sepsis. 11,12 The interleukin-7 receptor (IL-7R) is an immunomodulatory factor encoded by a gene located on chromosome 5p13. It exists in two forms: the membrane-bound interleukin-7 receptor (mIL-7R), which is predominantly expressed on immune cells and mediates IL-7 signaling, and the soluble interleukin-7 receptor (sIL-7R), which is secreted by fibroblasts and plays a role in maintaining immune homeostasis. 13 Clinical and animal model studies have revealed that deficiencies in IL-7 or IL-7R lead to impaired T-lymphocyte development and function. 14 Building on previous research demonstrating the diagnostic utility of sIL-7R in sepsis, 15 in this study, we explore the clinical significance of sIL-7R, in conjunction with other biomarkers and illness severity scores, for assessing immune function and predicting prognosis in patients with sepsis. Patients with sepsis who were treated in the emergency and critical care medicine departments at Beijing Chuiyangliu Hospital and Baoding No. 1 Central Hospital from December 2020 to June 2022 were initially considered in this study. The inclusion criteria were a diagnosis of sepsis according to the Third International Consensus Definitions for Sepsis and Septic Shock and age greater than 18 years. The exclusion criteria included a history of immunodeficiency disease or autoimmune disease, recent use of glucocorticoids or immunosuppressants, presence of allergic or tumor conditions, and a history -Abstract Truncated-

The Relationship Between Soluble Interleukin-17 Receptor Levels and CD3-Positive T Cells and Lymphocytes in Patients with Sepsis and Their Predictive Clinical Significance